Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Collections
    • Blog
  • Multimedia
    • Audio
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Collections
    • Blog
  • Multimedia
    • Audio
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
Clinical Pharmacology & Therapeutics

Declining Ingestions of OTC Cough and Cold Medications

AAP Grand Rounds September 2013, 30 (3) 27; DOI: https://doi.org/10.1542/gr.30-3-27
Quiz
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF

Source: Mazer-Amirshahi M, Reid N, van den Anker J, et al. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States Poison Centers [published online ahead of print June 12, 2013]. J Pediatr; doi: 10.1016/j.jpeds.2013.04.054OpenUrlCrossRef

PICO

Question: Among children <6 years of age, have national initiatives to restrict the use of over-the-counter cough and cold medications reduced unintentional ingestions, therapeutic errors, and adverse medical outcomes?

Question type: Occurrence

Study design: Retrospective cohort

Investigators from multiple institutions in Washington, DC conducted a retrospective analysis to determine if changes in the labeling and age recommendations for over-the-counter (OTC) cough and cold medications were associated with a reduction in the occurrence of “unintentional ingestions,” “therapeutic errors,” and serious medical outcomes. The investigators utilized data from the American Association of Poison Control Centers (AAPCC) National Poison Data System (NPDS) and poisonings reported to all US Poison Centers. They analyzed data on pediatric ingestions of OTC cough and cold medications coded as unintentional ingestions and therapeutic errors. Children were categorized into 3 age groups: <2 years, 2 to 5 years, and 6 to 12 years. For each age group, the frequency and severity of unintentional ingestions and therapeutic errors were compared between 2 time periods: 2005 to 2006 (pre-labeling and recommendation changes) and 2009 to 2010 (post-labeling and recommendation changes). Outcome severity was dichotomized as follows: (a) no effect or minor outcome (mild symptoms which rapidly resolve), or (b) moderate outcome (more pronounced or systemic symptoms), major outcome (life-threatening or resulted in permanent sequelae), or death.

In 2009 to 2010, the number of unintentional ingestions of OTC cough and cold medications was 9,170 for children <2 years of age, 42,503 for children 2 to 5 years of age, and 2,495 for children 6 to 12 years of age. Compared to 2005 to 2006, this represented declines of 40%, 33%, and 20%, respectively, in children aged <2 years, 2 to 5 years, and 6 to 12 years (P < .0001 for each comparison). Between these time periods, the frequency of therapeutic errors of OTC cough and cold medications also declined significantly by 75%, 46%, and 9% for children aged <2 years, 2 to 5 years, and 6 to 12 years, respectively. Moderate, severe, or fatal outcome after unintentional ingestions decreased 32% for children <2 years of age (P < .001) and 21% for children 2 to 5 years of age (P < .001). Moderate, severe, or fatal outcome after therapeutic errors did not change significantly between periods for any age group.

The authors conclude that restrictions on the use of OTC cough and cold medications has led to a reduction in unintentional ingestions, therapeutic errors, and adverse medical outcomes in children <6 years of age.

Commentary

Dr Frymoyer has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.

  • poisonings
  • cough medications
  • over-the-counter

Prior to 2007 as many as 1 in 10 children in the United States received OTC cough and cold medications each week. However, OTC cough and cold medications have not been shown to be effective in children,1 and in young children the potential for harm is clear.2 This discordance resulted in several changes to the labeling and new recommendations for OTC cough and cold medications in children. The key changes occurred between the 2 time periods examined in the current study and included a voluntary withdrawal by manufacturers of products directed at children <2 years of age (2007), guidelines by the FDA recommending against their use in children <2 years of age (2008), and a subsequent voluntary label change by manufacturers noting “do not use” in children <4 years of age (2008). In addition, the American Academy of Pediatrics supported the position that OTC cough and cold medications are not effective for children <6 years of age.3

A limitation to the current study is that it does not address trends in the overall use of OTC cough and cold medications in children, but instead only self-reported poisonings. A recent survey of parents found that two thirds were unaware of the FDA guidelines on OTC cough and cold medications in children <2 years of age.4 What are parents using as a guide for dosing since no information for children <4 years of age is available on the label? Additionally, direct causation of the decline in poisonings by OTC cough and cold medications cannot be established. Nonetheless, examination of medication misuse is informative. The temporal pattern of the large reduction of poisonings from OTC cough and cold medications in a national reporting system is highly suggestive of the impact that concerted efforts by the FDA, industry, and professional organizations had on improving the safety of medication use in children. Additionally, this study refutes concerns that OTC cough and cold medication poisonings would increase as parents turn to “off-label” use of formulations designed for older children and adults.

Continued guidance and education by pediatricians on the appropriate use (or nonuse) of OTC cough and cold medications in children, therefore, continues to be most important. Recent clinical studies supporting the use of honey for cough in children >1 year of age provide pediatricians a viable therapeutic alternative (see AAP Grand Rounds, March 2008;19[3]:285 and AAP Grand Rounds, February 2013;29[2]:146).

References

  1. ↵
    1. Smith SM,
    2. et al
    . Cochrane Database Syst Rev. 2012;8:CD001831; doi:10.1002/14651858.CD001831.pub4
    OpenUrlCrossRefPubMed
  2. ↵
    1. Schaefer MK,
    2. et al
    . Pediatrics. 2008;121(4):783–787; doi:10.1542/peds.2007-3638
    OpenUrlAbstract/FREE Full Text
  3. ↵
    American Academy of Pediatrics. Withdrawal of cold medicines: addressing parent concerns. Available at: www.aap.org/en-us/professional-resources/practice-support/Pages/Withdrawal-of-Cold-Medicines-Addressing-Parent-Concerns.aspx. Accessed July 3, 2013
  4. ↵
    1. Varney SM,
    2. et al
    . Pediatr Emerg Care. 2012;28(9):883–885; doi:10.1097/PEC.0b013e3182676518
    OpenUrlCrossRefPubMed
  5. ↵
    1. Paul IM,
    2. et al
    . Arch Pediatr Adolesc Med. 2007;161(12):1140–1145; doi:10.1542/peds.2011-3075
    OpenUrlCrossRefPubMed
  6. ↵
    1. Cohen A,
    2. et al
    . Pediatrics. 2012;130(2):465–471; doi:20.1542/peds.2011-3075
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

AAP Grand Rounds
Vol. 30, Issue 3
1 Sep 2013
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Declining Ingestions of OTC Cough and Cold Medications
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Declining Ingestions of OTC Cough and Cold Medications
AAP Grand Rounds Sep 2013, 30 (3) 27; DOI: 10.1542/gr.30-3-27

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Quiz
Share
Declining Ingestions of OTC Cough and Cold Medications
AAP Grand Rounds Sep 2013, 30 (3) 27; DOI: 10.1542/gr.30-3-27
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents
  • Current Issue
  • Past Issues
  • Collections
  • Editorial Board
  • Overview
  • CME Quizzes
  • MOC Claiming

Jump to section

  • Article
    • References
  • Info & Metrics
  • Comments

Related Articles

  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Effects of Prenatal Seafood Intake on Child Development
  • Pharmacokinetic-Modeled Treatment for Neonatal Abstinence Syndrome
  • Identifying Opioid-Exposed Infants: Universal Drug Testing in Moms
Show more Clinical Pharmacology & Therapeutics

Similar Articles

Subjects

  • Substance Abuse
    • Substance Abuse
  • Pharmacology
    • Therapeutics
    • Pharmacology
  • Journal Info
  • Editorial Board
  • Overview
  • Licensing Information
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • shopAAP
  • AAP.org
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics